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ABSTRACT 
 
 
Effects of Acute Sepsis on Renal Structure and Sympathetic Innervation in Mice  
by 
 
Tuqa Alkhateeb  
 
 
Sympathetic nerves are important for renal physiology and sepsis pathophysiology. A recent 
study showed sprouting of sympathetic nerves in spleen of septic mice. This study was done to 
test if renal sprouting of sympathetic nerves also happens and to investigate renal morphology 
in septic mice. Cecal ligation and puncture (CLP) was used to induce sepsis and kidneys were 
removed for evaluation. Bowman’s space was diminished with cortical bubble cells present 
suggestive of acute renal pathology, however, renal function was unchanged. Acute sepsis did 
not affect either renal sympathetic innervation or non-neuronal cholinergic cells. Mouse 
kidneys had more epinephrine (EPI) than norepinephrine (NE) in both groups. This is most 
likely due to uptake of epinephrine by renal sympathetic nerves and may have no correlation 
with sepsis. In conclusion, septic mice showed minor renal pathology and no evidence of acute 
sympathetic nerve sprouting. Further studies are needed to understand the mechanism and 
consequences of elevated EPI in mice kidney. 
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CHAPTER 1 
 
INTRODUCTION 
 
Sepsis 
Each year in the US, around 600,000 patients are diagnosed with the deadly spectrum of 
sepsis, with a mortality rate of 28-50% (Rangel-Frausto et al. 1995; Zeni et al. 1997; Angus et al. 
2001; Martin et al. 2003). Moreover, the cost per year of care given for septic patients is 
estimated to be $24 billion (Torio and Moore 2013). From 2004 until 2009, severe sepsis showed 
an average annual increase of 13% with the cumulative number of patients dying from sepsis 
rising over the years (Zarjou and Agarwal 2011). Sepsis usually starts off with an infection such 
as pneumonia, an intra-abdominal, urinary or skin/wound infection that may later develop into 
sepsis if not treated properly. Gram positive/negative bacteria are usually the source of infection 
in septic patients although fungal or protozoal agents may also be a cause (Pavlidis 2003; Kalra 
and Raizada 2006; Gaieski et al. 2010; Martin 2012). Moreover, the diagnosis of septic patients 
is not always direct as its symptoms are very similar to other diseases (Cunha and Shea 1996). 
Sepsis is identified as a confirmed infection along with at least two signs of the systemic 
inflammatory response syndrome (SIRS) (Martin 2012). SIRS is a massive state of inflammation 
throughout the body that may involve the patient having abnormal body temperature (<36°C or 
>38°C), respiration rate greater than 20/min, a heart rate greater than 90/min and white blood 
count to be greater than 12,000/mm³ or less than 4000/mm³ (Annane et al. 2005). If sepsis is not 
treated, then severe sepsis might develop that includes the septic symptoms along with organ 
dysfunction (Levy et al. 2003). 
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Early recognition and treatment may be life-saving; therefore if appropriate therapy is 
given within 6 h of suspected diagnosis, the patient’s chance of survival is improved (Iskander et 
al. 2013). However, even after receiving treatment, the patient is still at a high risk for repeated 
infections and organ damage with a diminished quality of life (Gentile et al. 2012). The human 
host system might differ between individuals when reacting to the early overwhelming 
inflammation stage due to many issues such as patient’s age, genetic factors, comorbidities, 
immunocompetence, as well as the virulence of the microbes (Boomer et al. 2014), and 
therefore, an individualized therapy is required. Certain guidelines and protocols are helpful to 
direct treatment in improving septic patients’ survival. The recommendations include early 
disease recognition, rapid aggressive IV fluid resuscitation with 0.9% normal saline for tissue 
reperfusion, oxygen support, broad-spectrum antibiotics given as empiric therapy (Howell and 
Davis 2017) and sometimes use of vasopressors in septic shock (Beale et al. 2004). Moreover, 
the source of infection can be eradicated by removing the infected or necrotic tissue and drainage 
of pus.  
Pathophysiology of Initial Inflammatory Stage 
Sepsis is characterized as a SIRS in response to an infection, stimulated by production of 
initial proinflammatory cytokines such as IL-1, TNF-α, IL- 12, IL-8, IL-6, high mobility group 
box 1 (HMGB1) and acute phase proteins (Charalambos et al. 2000; Chaudhry et al. 2013; Xiao 
et al. 2015). Currently, there are still not enough details describing the exact pathways 
underlying the pathophysiology of sepsis to help prevent the development of SIRS and sepsis in 
humans.  In the primary stage of sepsis, a ‘cytokine storm’ is thought to occur with intense 
interaction between the infectious organisms and the host pathogen-recognition system or innate 
immunity (Boomer et al. 2011; Chaudhry et al. 2013). The interaction is characterized by 
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pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns 
(DAMPs) with Pattern Recognition Receptors (PRRs) (Wiersinga et al. 2014). PAMPs are 
related to septic microorganisms that include peptidoglycan, lipoplysaccharide (LPS), flagella 
and lipoteichoic acid (Yoshimura et al. 1999; Hayashi et al. 2001; Akira et al. 2006) while 
DAMPs are endogenous products released from cells upon cellular injury (Willart and 
Lambrecht 2009) with heat shock proteins (HSPs), high mobility group box-1 (HMGB1), 
fibrinogen and hyaluran related to sepsis pathology (Cinel and Opal 2009). Innate immune cells 
such as macrophages, leukocytes and dendritic cells possess PRRs on their exterior surface 
(Janeway and Medzhitov 2002). Toll like receptors (TLRs) are PRRs with TLR4 specifically 
playing an important role in the inflammatory stage of sepsis (Wiersinga 2011). When TLR4 
interacts with the various PAMPs and DAMPs, multiple transcriptional factors are activated, 
most importantly the nuclear factor, NF-κβ, that further activates genes causing elevated blood 
levels of pro-inflammatory cytokines (Janeway et al. 2001; O’Neill et al. 2007; Castellheim et al. 
2009). Moreover, after being triggered by an overwhelming initial stimulus, neutrophils and 
macrophages activate the complement system (Janeway et al. 2001). The clotting cascade 
pathway is enhanced by cell adhesion of the neutrophil–endothelial system and leukocyte-
endothelial system resulting in endothelial cell impairment (Granger and Senchenkova 2010). 
Nitric Oxide (NO), which is a potent vasodilator, is elevated in the inflammatory phase of sepsis 
along with reactive oxygen species (ROS) also present in very high amounts compared to the 
antioxidant levels (Galley 2011).   
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Renal Structure  
The kidney’s role in the human body is exceptional in that it helps to maintain the overall 
homeostasis by controlling water and electrolyte levels, acid/base balance, blood pressure and 
waste products excretion (Koeppen 2009; Wadei et al. 2012). The kidneys receive around 10-
25% of the cardiac output, which is supplied by the renal arteries (Young 2010; Basile et al. 
2012). The blood then undergoes several processes through the afferent arteriole including 
glomerular filtration, tubular reabsorption and secretion. These three steps lead to urine 
formation that is excreted and constitutes only 1% of the primary filtered blood. There are 
around one million nephrons in the kidney, each consisting of the renal corpuscles and different 
types of tubules (Murawski et al. 2010). The two main structures in the kidney are the cortex and 
the medulla. The cortex receives the greater blood supply (Badzynska et al. 2002) with renal 
corpuscles and distal and proximal convoluted tubules present in that region. The medulla has 
Loops of Henle and the collecting ducts. Glomerular filtration is the primary process that affects 
the body’s fluid where urine formation begins (Holecheck 2003). This occurs in the renal 
corpuscles that are made up of the glomerulus and the Bowman’s capsule (Pollak et al. 2014). 
The urinary/Bowman’s space is the space between the Bowman’s capsule and the glomerulus 
and this is where the glomerular plasma filtrate collects as it leaves the capillaries through 
the filtration membrane (Pollak et al. 2014). The filtrate is further modified as it passes through 
the nephron by tubular reabsorption and/or tubular secretion (Blaine et al. 2015). After leaving 
the Bowman’s space, the filtrate passes through the proximal convoluted tubules by reabsorbing 
certain amounts of the salt, water and electrolytes (Blaine et al. 2015).  Then it further passes 
through the descending and ascending Loops of Henle, the distal convoluted tubule and finally 
the collecting duct. Tubular and glomerular injury may occur due to alterations in structure of 
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endothelial cells where neutrophils, macrophages, natural killer cells and lymphocytes pass in 
large amounts into the kidneys (Kinsey and Okusa 2012). This may lead to a dysfunction in the 
reabsorption and secretory mechanisms as well as the glomerular permeability. Visible damage 
to renal structures may vary, according to severity, from small changes in cellular morphology to 
tubular necrosis, also known as acute tubular necrosis (ATN) (Basile et al. 2012). 
Glomerular filtration rate (GFR) may be determined from the equation of Net Filtration 
Pressure (NFP) where     NFP = Pc – PB – πc (Pc is the hydrostatic pressure in the glomerular 
capillaries, PB is the hydrostatic pressure in Bowman’s space and πc is the oncotic pressure in the 
glomerular capillaries; Kellum 2015). The hydrostatic pressure is the pressure exerted directly by 
fluid on the capillary walls of the glomerulus or Bowman's capsule (Deshmukh et al. 2009).  
Researchers found that cystatin C (CystC) in the blood is not influenced by sepsis and 
therefore is a potentially valuable specific and sensitive marker of kidney function in septic 
conditions (Gerbes et al 2002; Schuck et al. 2002; Mårtensson et al. 2012). CystC is a cysteine 
protease inhibitor found in the lysosomes of all nucleated cells and participates in protein 
metabolism inside the cell (Abrahamson et al 1990; Laterza et al. 2002). In the kidney, CystC is 
filtered in the glomerulus, reabsorbed, degraded by the proximal tubules’ epithelium and passed 
into the urine (Tenstad et al. 1996; Zappitelli et al. 2006). Neither inflammation, weight, muscle 
mass, gender nor diet may affect the CystC value (Grubb et al. 1985; Simonsen et al. 1985; 
Abrahamson et al 1990). Moreover, CystC may be useful for determining GFR (Finney et al. 
2000) since in several studies, an obvious relationship was linked between the CystC and GFR in 
adults (Simonsen et al. 1985; Bökenkamp et al. 1998)  
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Sepsis and Acute Kidney Injury   
As sepsis severity increases in patients, the risk factor of development of acute kidney 
injury (AKI) also increases (Lopes et al. 2009). It was found that 26% to 50% of patients who 
developed AKI had sepsis already present initially, compared with only 7% to 10% who had 
primary kidney disease–associated AKI (Bagshaw et al. 2008). AKI leads to an impaired 
generation of urine, hypertension by reabsorbing excess water and salt and an imbalance between 
acid/base and electrolyte homeostasis (Morrell et al. 2014; Blaine et al. 2015).                                
Sepsis-associated AKI (SA-AKI) carries a different pathophysiology and a higher 
severity of illness than AKI not related to sepsis, and therefore different therapeutic interventions 
should be given (Alobaidi et al. 2015). Although SA-AKI incidence is 50% (Alobaidi et al. 
2015), its pathophysiology is not completely known yet with no specific therapy present (Doyle 
and Forni 2016). Recent studies have suggested that SA-AKI might not be always linked with a 
decrease in renal blood flow (RBF) due to a decrease in cardiac output (Alobaidi et al. 2015). In 
fact, even if the RBF is not decreased, distortion in the renal microcirculation may still happen 
(Legrand and Payen 2011). In addition, low blood pressure was not correlated with AKI in 
critically ill patients with severe sepsis (Chawla et al. 2007). An important hemodynamic 
concept proposed in SA-AKI is elevated renal vascular resistance (RVR) with microvascular 
distortions in the kidney leading to intraglomerular thrombosis (Zarbock et al. 2014). 
Unfortunately, treatment of SA-AKI has advanced little during the last several decades and 
therefore, more studies are needed to investigate the renal microvascular alterations that occur 
during SA-AKI. 
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The Sympathetic Nervous System  
Recent studies have proposed that the autonomic nervous system (ANS) may have an 
influence on the inflammatory response, therefore sepsis might not only affect the immune 
system but might also interact with the ANS (Tracey 2002; Flierl 2007). The sympathetic 
nervous system (SNS) in the kidney is vital for blood pressure regulation, water and electrolyte 
reabsorption and renin secretion (Ritz et al. 1998). Catecholamines such as NE, EPI and 
dopamine (DA) play an important role after being released in the circulation during the 
flight/fight response when the SNS is stimulated (McCorry 2007). In the initial stages of sepsis, 
elevated concentrations of catecholamines such as EPI and NE are present in the circulation that 
enhances the initial inflammatory response (Rittirsch et al. 2008). Previously, it was believed that 
catecholamine synthesis was related solely to the SNS; however leukocytes and phagocytes may 
also contribute to the catecholamine synthesis as leukocytes also express adrenergic receptors 
(Bergquist et al. 1994; Flierl 2007).  
 During sepsis, the catecholamines are increased in the circulation and when they interact 
with the adrenergic receptors in the kidneys, this may cause a vasoconstriction of afferent 
arterioles that may lead to a decrease in RBF (Casellas et al. 1985). NE is the main 
neurotransmitter released by the renal sympathetic nerves (Pongratz and Straub 2014) with its 
effects exerted on the kidney passing through β1-adrenergic receptors in juxtaglomerular cells 
that elevate renin secretion and helps regulate blood pressure (Kopp 2011). Studies have shown 
that nerve endings of glomerular arterioles and juxtaglomerulus apparatus (JGA) in the kidney 
have NE and therefore are sympathetic nerves (Barajas 1979).  
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When there is an elevated level of renal SNS activity and an activation of efferent 
sympathetic nerves, α1 and β1 adrenergic receptors are stimulated that lead to renin release, a 
decrease in RBF along with increased reabsorption of sodium and fluid retention (Wyss and 
Carlson 1999). The renin-angiotensin system is also activated through the feedback mechanism 
with the ANS and therefore leads to an exacerbated level of SNS activity (Manrique et al. 2009). 
This elevated level of SNS activation may constitute deleterious effects on the kidney due to the 
prolonged vasoconstriction on afferent arterioles that consequently leads to a decrease in RBF 
(Smyth et al. 1985; Kannan et al. 2014). In conclusion, the adrenergic receptors stimulated due to 
SNS activation during initial stages of sepsis stimulates the pro-inflammatory responses and 
worsens the adverse effects, although the complete pathways that cause these effects are still to 
be investigated. 
Hypothesis and Specific Aims 
The level of sympathetic nerve activation is a major determinant of RBF and GFR. 
Sepsis, like other stress conditions, is characterized by an increase in the sympathetic nerve 
activity (SNA), as shown by the increase in plasma catecholamine levels, and in directly 
recorded SNA (Hahn et al. 1995). There is evidence that sepsis can induce sprouting in 
sympathetic nerve fibers as studies have shown elevated tyrosine hydroxylase (TH) expression in 
the gut of septic rats at both 2 h and 20 h where sepsis was induced by CLP (Zhou et al. 2004). 
TH is the rate limiting enzyme in the catecholamine synthesis pathway. Moreover, rheumatoid 
arthritis (RA) elevated the sympathetic nerve fiber density in the spleen of a rat model (Lorton et 
al. 2005).  In another study, sympathetic nervous activity was elevated in the heart and kidney of 
conscious septic sheep model induced by intravenous administration of E. coli. In the kidney, the 
effect was only seen after 20 h (Calzavacca et al. 2014).  
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A previous study has shown that sympathetic nerve fiber density in the spleen was 
elevated during acute sepsis due to a neuronal sprouting response (Hoover et al. 2014). The 
researchers used the same sepsis model in our experiments, and there was an upregulation of 
nerve growth factor (NGF) in the spleen and consequent rapid growth of noradrenergic nerve 
fibers. This finding suggests the possibility that the effects of NGF could be widespread in 
sepsis. Therefore, to test if the same effect is happening in the kidney we conducted this project. 
Our hypothesis was that during sepsis, which is a stressful situation, the renal sympathetic 
innervation will increase. Furthermore, we proposed that the renal sympathetic innervation will 
increase 16 h after CLP, and so if prolonged, it may lead to vasoconstriction of afferent arterioles 
in the kidney that might be detrimental to kidney function in hindering the normal filtration 
process from occurring with renal structural changes evident.   
The first aim was to evaluate the renal sympathetic nerve abundance and renal non-neuronal 
cholinergic cells during sepsis using ChAT-eGFP mice. ChAT-eGFP mice have the GFP (green 
fluorescent protein) gene inserted downstream of the promoter for choline acetyltransferase 
(ChAT), the enzyme required for the synthesis of acetylcholine. The first aim was achieved by:  
1. Immunolabelling the kidney tissues for the sympathetic nerve marker, TH and for 
GFP to identify non-neuronal cholinergic cells. 
2. Analyzing confocal microscopic images for TH nerves and GFP non-neuronal 
cholinergic cells. 
3. Measuring TH and GFP protein content in our kidney samples by western blotting 
4. Measuring renal catecholamines by high performance liquid chromatography 
(HPLC). 
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The second aim was to investigate the renal morphological and functional changes by:  
5. Staining the kidney tissues with Hematoxylin and eosin (H & E) and periodic acid 
schiff (PAS) reagents. 
6. Measuring the renal function using serum CystC as the marker 
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CHAPTER 2 
 
MATERIALS AND METHODS 
 
Animals Used 
Wild-type C57BL/6 adult male mice were purchased from Harlan Laboratories and 
used to investigate renal morphology, histology, and CystC levels. Male ChAT-eGFP 
transgenic mice were purchased from Jackson Laboratories and used for western blotting, 
renal catecholamine measurements, and immunohistochemistry. Both strains of mice used 
in the experiments were 4-6 months of age.  
The animals had a light/dark cycle of 12 hours each with access to food and water in 
their respective cages. Animal protocols were approved by the East Tennessee State 
University Committee on Animal Care and conformed to guidelines of the National 
Institutes of Health as published in the Guide for the Care and Use of Laboratory 
Animals (Eight Edition, National Academy of Sciences, 2011).  All mice were maintained 
in the Division of Laboratory Animal Resources at ETSU.  
 
 Cecal Ligation and Puncture (CLP) Surgery  
CLP was the surgical method used to induce polymicrobial sepsis in male C57BL/6 and 
ChAT-eGFP mice. Both strains were 4-6 months of age at the time of surgery. Anesthesia was 
induced with 5% isoflurane (100% O2 at 1 ml/min) in a separate chamber. Mice were transferred 
to the surgery area, and 2% isoflurane was used to maintain anesthesia during the surgery 
procedure. The cecum was externalized through a 1 cm abdominal midline incision. The entire 
cecum was then ligated just distal to the ileocecal junction with a 0 suture and punctured once 
with a 20 gauge needle in an avascular region near the distal end.  After manually extruding a 
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small amount of feces from the puncture site, the cecum was reinternalized and the abdomen was 
closed in two layers. The mice then received a subcutaneous injection of resuscitation fluid (1 
mL lactated Ringers solution) after surgery. The mice never received a post-surgery antibiotic. 
Mice were euthanized with isoflurane anesthetic 16 h post-surgery. Sham mice were used as a 
control for surgery, as they underwent similar surgery to the CLP procedure, but without ligation 
or puncture of cecum. Instead the cecum was externalized and then immediately reinternalized. 
 
Immunohistochemistry 
  ChAT-eGFP mice were already available, and we decided to use them for investigating 
our main aim which was looking at the renal sympathetic nerve density 16 h after sepsis surgery. 
Use of these transgenic mice allowed us to also investigate the presence of non-neuronal 
cholinergic cells (i.e., eGFP+) in the kidney and determine if the abundance of these cells was 
altered in sepsis. Therefore, the kidney tissues were double-labeled for the sympathetic nerve 
marker TH, a rate limiting enzyme for biosynthesis of catecholamines, and for eGFP.  
ChAT-eGFP mice that underwent CLP and sham surgeries were euthanized with 
isoflurane at 16 h post-surgery. Kidneys were collected and stored in 4% paraformaldehyde in 
0.01M PBS at 4°C overnight. They were then cryoprotected in 20% sucrose, frozen in dry ice 
and stored at -80°C. Frozen, 100 m longitudinal kidney sections of CLP and sham mice were 
cut using a cryostat and stained free-floating in a 12-well culture plate. After the kidney tissue 
was cut, the renal sections were rinsed four times in 0.1M PBS, 10 minutes each. Then they were 
incubated with permeabilizing solution (0.5% BSA + 0.4% Triton X-100) in PBS for 20 min at 
room temperature. Tissues were then incubated in blocking solution (10% Normal Donkey 
Serum in 1% BSA + 0.4% Triton-X100 in PBS) for 2 h at room temperature. Kidney sections 
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were incubated for two days at 4°C following the application of the primary antibodies,  anti-
tyrosine hydroxylase rabbit polyclonal antibody (1:500 dilution, Pel-Freez, P40101-150) and 
anti-GFP chicken polyclonal antibody (1:2000 dilution, Abcam AB13970) in 1% BSA + 0.4% 
Triton X-100 in PBS.  After two days, the tissues were washed with 0.1M PBS five times, 10 
min each and rinsed with permeabilizing solution (0.5% BSA + 0.4% Triton X-100) in PBS for 
20 min at room temperature. Tissues were then stained with AlexaFluor® 594 conjugated 
donkey anti-rabbit (1:200, Molecular Probes, A21207) and AlexaFluor® 488 conjugated donkey 
anti-chicken (1:200, Jackson ImmunoResearch, 703545155). The secondary antibodies were left 
on overnight at 4°C. Tissues were then washed with 0.1M PBS six times and placed on slides. 
Coverglasses were attached using CitiFluor mounting medium.   
 
Confocal Microscopy 
The kidney tissues obtained from immunohistochemistry were visualized under a 
confocal laser-scanning microscope. Confocal images were obtained with a Leica TCS SP8 
Confocal Microscope system with dual line switching excitation (488 nm and 543 nm). Confocal 
microscopy was used to capture images of the double-labeled kidney tissues. 90 optical sections 
were collected per field, and multiple fields were stitched together to create a montage. 
Maximum projection images of three montages were evaluated per mouse. TH nerve density and 
GFP cell density of each CLP and sham confocal image was quantified using ImageJ software, 
and group values were compared using a two way-unpaired t-test.  
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Renal Morphology and Histology 
The next aim was to investigate if acute sepsis resulted in any renal pathological changes. 
C57BL/6 mice were euthanized 16 h after surgery and the left kidneys were collected and fixed 
in formalin overnight. The next day, the kidneys were put in 70% ethanol and embedded in 
paraffin. Using a microtome (Microm), 5 μm short axis sections were cut. Routine 
Hematoxylin and Eosin (H & E) staining as well as Periodic acid–Schiff (PAS) Staining were 
done to look at renal morphology. Images of the renal corpuscles were collected at 40X 
magnification using a microscope equipped with a digital camera and QCapture software. Stereo 
Investigator software was used to measure the area of the glomerulus and Bowman’s capsule of 
each renal corpuscle. In addition, the area of the Bowman’s space in each renal corpuscle 
measured was calculated by subtracting the area of the glomerulus from the area of the 
Bowman’s capsule. 90 total renal corpuscles were analyzed, 15 from each mouse (n=3 per 
group). Measurements were analyzed by an unpaired t-test. 
 
Western Blot of TH and GFP 
 To analyze TH and GFP protein content in the kidneys, western blot analysis was done. 
Kidney tissue samples were dissected, frozen in liquid nitrogen, and stored at −80°C. Later on, 
kidneys were thawed and weighed. Thawed kidneys had 100X times buffer added according to 
their individual weights. The buffer consisted of ice-cold 10X PBS and 1% Tween 20 with Halt 
protease and phosphatase inhibitor cocktail (Thermo Scientific, 78440). Each kidney was 
homogenized with a hand-held homogenizer for 10 s per sample and placed back on ice. Then 
the homogenized samples were centrifuged at 10,000 rpm for 20 min in Eppendorf tubes. The 
supernatant was then removed and aliquoted into 100 μl tubes for storage at −20°C. The protein 
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concentration of tissue lysates was determined by a BCA Protein Assay Kit (Thermo Scientific, 
T23227). After the calculated protein and Lamellil Buffer (NuPage LDS Sample Buffer 4X, 
Thermo Scientific, NP0008) were added, the samples were vortex-mixed for 5 s, boiled for 5 min 
and then centrifuged for 5 s. 20 μg protein/sample aliquots with a total volume of 20 μL/well 
were separated on 4-12% Bis-Tris Gel (NuPage Novex, NP0335BOX) for 50 min at 200V with 
MOPS SDS Running Buffer (NuPage, NP0001). Proteins from the gel were then 
electrophoretically transferred onto a 0.45-μm nitrocellulose membrane (Amersham Protran, 
10600002) using Tris-Glycine Transfer Buffer (Fisher BioReagents, BP1306-4). Blots were 
washed in PBS and Tween 20. The membrane was blocked in a 2.5% BSA buffer and the 
membranes were incubated at 4°C overnight with the respective antibodies in 0.1M PBS: anti-
tyrosine hydroxylase rabbit polyclonal antibody (1:2000 dilution, Pel-Freez, P40101-150) , anti-
GFP chicken polyclonal antibody (1:4000 dilution, Abcam, AB13970) and anti-β actin rabbit 
polyclonal antibody (1:500 dilution, Thermo Scientific, RB9421P0) to normalize for protein 
loading. The following day, the membrane was washed twice with PBS and Tween 20 before 
being incubated with a goat anti-chicken horseradish peroxidase (HRP)-linked antibody (1:5000 
dilution, Jackson-ImmunoResearch, 103-035-155) and goat anti-rabbit HRP conjugate (1:5000 
dilution,  Jackson- ImmunoResearch)  for 2 h at room temperature and then washed three times. 
The proteins on the membrane blots were developed by exposing them to Super Signal West 
Dura Extended Duration Substrate (Thermo Scientific, 34075) by using 2 ml of each of bottles A 
and B. Images were generated using G:BOX (Syngene) and the intensity of the luminescent 
signal of the resulting bands was captured by Quantity One Software (Bio-Rad Laboratories). In 
the volume analysis settings of the software, local background subtraction method was selected 
with the data units to be intensity. For each of the CLP and sham kidney samples, TH was 
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normalized by dividing the adjusted volume of TH by the respective β-actin adjusted volume for 
each sample. Similarly for GFP, the adjusted volumes of GFP was divided by the respective 
adjusted volume of β-actin. The normalized data measurements were analyzed between the sham 
and CLP groups using an unpaired t-test.  
Measurement of Renal Catecholamines 
C57BL/6 mice were euthanized 16 h after surgery and perfused with 0.1M PBS for 
around 3 min through the left ventricle to remove plasma catecholamines. The right kidneys 
were then dissected, flash frozen in liquid nitrogen and finally stored at -80°C. Kidneys were 
separately weighed and inserted in a 2ml microcentrifuge tube with a ceramic bead where 1ml of 
buffer (0.1M perchlorate with 1μg/ml dihydroxybenzoic acid (DHBA) as internal standard) was 
added to each kidney sample tube. Using a FastPrep-24 tissue homogenizer (MP Biomedicals, 
116004500), the kidneys were homogenized at 4.0 M/S for 10 sec three consecutive times. While 
in the same tube, they were centrifuged at 13,000 rpm for 10 min. 700 μl of supernatant was 
transferred to a CoStar-Spin-X centrifuge filter tube (0.22 μm, prewashed with 700 μl 0.1M 
perchlorate) and centrifuged at 13,000 rpm for 6 min. The tube filter was then removed and the 
samples were vortex-mixed. Finally, 50 μl of each sample filtrate was added to 150 μl of 0.1M 
perchlorate in a 300 μl TPX HPLC vial with a silicone/PTFE septa screw-cap (MicroSolv™) and 
refrigerated in a 4ºC autosampler tray. The injection volume was 5 μl and each sample was 
analyzed for a duration of 40 min at a range of 20nA. The HPLC setup consisted of Antec 
Decade ǀǀ Analyzer with VT-03 flow cell, ISAAC electrode and ALF-115 column (C18) with the 
oven temperature set at 35ºC. The flow rate was 50 μl/min and pressure was 188 bar. The mobile 
phase composition consisted of 50 mM phosphoric acid, 50 mM citric acid, 8 mM potassium 
chloride, 0.1 mM EDTA, 10% methanol as an organic solvent, 500 mg/L of 1-octanesulfonic 
24 
 
acid sodium (OSA) and an adjusted pH of 3.25. The peak heights of each of the catecholamines 
(NE, EPI and DA) were used for the calculations. Catecholamine levels (NE, EPI and DA) were 
normalized by dividing the peak heights of each catecholamine by the height of DHBA in its 
respective sample. Afterwards, each ratio was divided by its respective sample kidney weight to 
obtain renal catecholamine levels. The data measurements were analyzed between the sham and 
CLP groups using an unpaired t-test. 
Measurement of Serum CystC Concentration  
C57BL/6 mice were euthanized 16 h after surgery (n =6 per group). Weights were taken 
that ensured an equal distribution of weights in each group. Immediately after termination, 500 
μl of blood was collected from the abdominal vena cava and 150-200 μl of serum was collected 
from blood using a serum separator. Serum collected from each mouse sample was put on wet 
ice during collection and further stored at -80°C. Serum was collected in order to measure levels 
of the protein CystC, an indicator of renal function, using the cystatin C mouse ELISA kit   
(Biovendor, RD291009200R). The frozen serum samples were prepared for assay by removing 
them from the -80°C freezer and allowing them to thaw. Afterwards, each serum sample was 
vortexed for approximately 5 s to ensure homogeneity. The samples were diluted 500x with 
Dilution Buffer in two steps: 1) 1:10 dilution of serum to Dilution Buffer, which was prepared by 
combining 10 l of serum with 90 l of Dilution Buffer (Solution A) and 2) 1:500 dilution of 
solution A to Dilution Buffer, which was prepared by combining 10 l of Dilution A with 490 l 
of Dilution Buffer (Dilution B). All dilutions were vortexed after combining to ensure 
homogeneity. Standards and controls were prepared according to instructions using Dilution 
Buffer. 100 l diluted standards, positive and negative controls, a blank, and samples were 
pipetted into the appropriate wells of the plate, in duplicate. The plate was incubated at room 
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temperature for 1 h on a plate shaker at 300 rpm. The wells were then washed three times using a 
multi-channel pipette with 350 l of Wash Solution. After aspirating the Wash Solution from 
each well during the third wash, the plate was inverted and tapped firmly against bench paper to 
ensure each well was dry. 100 l of Biotin Labelled Antibody was then added into each well. 
The previously described steps of incubating, shaking, washing, and inverting the plate were 
repeated. 100 l of Streptavidin-HRP Conjugate was added to each well. The plate was 
incubated for 30 min, as previously described, and then inverted. 100 l of Substrate Solution 
was added to each well. Aluminum foil was used to cover the plate and the substrate solution 
was allowed to incubate for 10 min at room temperature. At 10 min, 100 l of Stop Solution was 
added to each well to stop the color development. Finally the absorbance of each well was 
obtained using a microplate reader set to 450 nm with reference wavelength set to 600 nm. The 
readings at 600 nm were subtracted from the readings at 450 nm. After subtraction, the mean 
absorbance was calculated for the duplicate standard absorbance readings. The standard curve 
was drawn by plotting the mean absorbance of the standards against their known concentrations 
and fit to symmetrical sigmoidal regression. From the standard curve, the measured 
concentration of diluted samples were obtained. The actual serum CystC concentrations were 
calculated by adjusting for the dilution factor (multiplying by 500), to obtain a concentration of 
ng/ml. Serum CystC concentrations were compared between sham and CLP groups and analyzed 
using an unpaired t-test. 
Statistical Analysis 
Graph Pad Prism 6 was used for the statistical analysis and generation of graphs. The 
groups being compared were CLP and sham in the measurements of the Bowman’s space area, 
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serum CystC concentration, TH nerve and eGFP non-neuronal density, TH and eGFP protein 
content, and renal catecholamines. Data were summarized by the mean and standard error 
(SEM). Group mean responses were compared by two-tailed unpaired t-test where p-values of 
0.05 or smaller were considered significant. 
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    CHAPTER 3 
RESULTS 
 
CLP Renal Tubules Had Bubble Cells Present 
To investigate the renal morphological and structural changes in septic kidneys, 
hematoxylin and eosin (H & E) (Figure 1) and periodic acid Schiff (PAS) (Figure 2) staining of 
the kidney tissues was done. The H & E staining revealed bubble cells in the cortical renal 
tubules of the CLP mice with none present in the sham group. Graber et al. suggested that these 
bubble cells represent viable renal tubular cells that have been injured sub-lethally (Graber et al 
1991). This acute pathology is thought to be reversible.  
                 
 
 
 
 
 
 
 
 
 
 
                         CLP                                                                            Sham 
 
Figure 1: Bubble cells seen in CLP renal tubules 16 h post-surgery. Kidneys of wild type mice 
were paraffin-embedded, cut at five microns and stained with H & E. Arrows pointing at bubble 
tubular cells. Representative light photomicrographs of each group are shown. 
 
Bowman’s Space was Significantly Diminished in Renal Corpuscles of Septic Mice 
From the PAS staining photographs (Figure 2), measurements of the area of renal 
corpuscle components (i.e., glomerulus, Bowman’s capsule and Bowman’s space) were done 
using Stereo Investigator. Bowman’s Space was calculated by subtracting the glomerulus from 
25 m  25 m  
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the Bowman capsules’ area. There was a statistically significant decrease in Bowman’s space 
area in the CLP kidneys compared to the sham kidneys 16 h post surgery. (Sham: 633 ± 92 
and CLP: 304 ± 33 μm²; n=3 per group, p = 0.0279). This may indicate a disruption in the 
glomerular filtration capacity of the CLP kidneys.  
A.                                                                           B.      
    
                  
 
 
Figure 2: Light photomicrographs of PAS Stained kidneys. A. Diminished Bowman’s space in 
(A) CLP renal corpuscles compared to (B) Sham renal corpuscles of wild type mice. Kidneys 
were paraffin-embedded, cut at five microns, and stained with PAS reagent. Arrows pointing at 
Bowman’s space. B. Quantification of Bowman’s space of PAS stained kidney tissue. Statistical 
analysis shows that the CLP mice had significantly smaller Bowman’s space than the sham 
groups (p = 0.0279). Data was expressed as the mean + SEM (n = 3 mice/group). 
 
 
Renal Function Was Not Impaired in CLP Mice 
 
PAS staining revealed that Bowman’s space was diminished in CLP kidneys, and 
therefore, to further confirm if renal function was reduced, serum CystC was the renal function 
marker measured. Serum CystC has been indicated to be a more reliable and better marker than 
serum creatinine for renal function in mice, especially in AKI models (Sahsiver et al. 2009; Song 
A.  
B. 
25 m  
25 m  
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et al. 2009).  Evaluation of the renal function in both groups by ELISA revealed that there was 
no significant difference in serum CystC levels between sham and CLP groups (Sham: 376 ± 22 
and CLP: 325 ± 11 ng/ml; n=6 per group, p > 0.05; Figure 3). This indicated that glomerular 
filtration capacity was not altered although pathological changes were evident. 
 
 
Figure 3. Renal function in septic kidneys 16 h post surgery. Serum was obtained from blood 
samples by a serum separator and CystC serum levels were measured by cystatin C mouse 
ELISA kit. No statistical difference in serum CystC levels occurred (p = 0.0626). Data was 
expressed as the mean + SEM (n = 6 mice/group). 
 
 
Renal Sympathetic Innervation During Sepsis 
  
Since a previous study, using the same model showed that the sympathetic innervation 
had increased in the spleen (4), our second aim was to evaluate the sympathetic nerve abundance 
in the kidney during sepsis. Therefore, the kidney tissues were immunolabeled for the 
sympathetic nerve marker, TH. Confocal microscopic images were obtained and further used for 
analysis (Figure 4). After analyzing the percentage of TH nerve density present in the renal 
cortex, there was no significant difference between the two groups. (Sham: 1.43 ± 0.114 and 
CLP: 2.25 ± 0.297 % area; n=3 per group, p > 0.05).  
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Figure 4: Sympathetic innervation in ChAT-eGFP mice 16 h post-surgery. A: Confocal 
microscopic images of kidney tissue stained with TH post Sham (A) and CLP (B) surgery. 
Kidney cortical tissue is labeled with AlexaFluor® 594 conjugated donkey anti-rabbit secondary 
antibody. Bars are 1000 μm. B: Quantification of TH nerve density of confocal images using 
ImageJ. Statistical analysis shows that there was no increase in sympathetic nerve density in 
septic kidneys (p = 0.061). Data was expressed as the mean + SEM (n = 3 mice/group)  
 
Expression of TH in the Kidney 
In order to validate the TH nerve density results, we further measured the TH protein 
content in our kidney samples from both CLP and sham groups by western blotting (Figure 5). In 
the western blot analysis we studied the whole kidney, while the TH nerve density measurement 
was focused more on the cortical region of the kidney where the vast majority of nerves are 
located. Sepsis did not affect the renal TH expression as there was no statistically significant 
difference between sham and CLP groups. (Sham: 151 ± 22 and CLP: 116 ± 12 (arbitrary units); 
n=6 per group, p > 0.05).    
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Figure 5: TH protein content in ChAT-eGFP septic kidneys. A: Representative Western blot of 
renal TH protein; B: Densitometry of TH bands normalized to β-actin, expressed as arbitrary 
units with no statistical difference between groups (p = 0.1898). Protein was extracted from the 
kidney and used for western blot analysis. β-actin was used as loading control. Data was 
expressed as the mean + SEM (n = 6 mice/group). 
 
 
As stated previously, TH is the rate limiting enzyme in the catecholamines’ synthetic 
pathway. This pathway includes NE, EPI and DA with NE known to be the main 
neurotransmitter involved in sympathetic nerves. After measuring renal catecholamines by 
HPLC at 16 h post-surgery, no differences between groups were detected for NE (Sham: 1331 ± 
28 and CLP: 1460 ± 165ng/g), EPI (Sham: 10068 ± 824 and CLP: 11487 ± 1275 ng/g) or DA 
(Sham: 183 ± 99 and CLP: 162 ± 31 ng/g; n=6 per group, P > 0.05) (Figure 6). This goes hand in 
hand with our previous TH nerve density results as well as the TH protein expression data that 
had no change between the two groups.   
 
B. 
A. 
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Figure 6. Renal catecholamine levels 16 h post surgery. A. NE normalized data. (p = 0.4595)    
B. EPI normalized data. (p = 0.3717) C. DA normalized data. (p = 0.8448). Kidneys were 
homogenized and catecholamine levels were measured by HPLC. DHBA was used as an internal 
standard. Peak heights of each of the catecholamines were used for analysis. No statistical 
difference in renal catecholamine levels of ChAT-eGFP mice (p>0.05). Data was expressed as 
the mean + SEM (n = 6 mice/group).  
 
Non-Neuronal Cholinergic Cells Were Not Altered During Sepsis 
The kidney tissues were immunolabeled for eGFP to identify non-neuronal cholinergic 
cells. Confocal microscopic images were obtained and further used for analysis (Figure 7). After 
analyzing the percentage of eGFP non-neuronal density present in the renal cortex, there was no 
significant difference between the two groups. (Sham: 1.43 ± 0.43 and CLP: 0.79 ± 0.05 % area; 
n=3 per group, P > 0.05).  
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Figure 7: Non-neuronal cholinergic cells during sepsis. A: Confocal microscopic images of 
ChAT-eGFP kidney tissue stained with GFP 16 h post Sham (upper panel) and CLP (lower 
panel) surgery.  Kidney cortical tissue is labeled with AlexaFluor® 488 conjugated donkey anti-
chicken secondary antibody. Bars are 1000 μm. B: Quantification of GFP non-neuronal density 
of confocal images using ImageJ. Statistical Analysis shows that there was no significant 
difference between CLP and sham groups (p = 0.2166). Data was expressed as the mean + SEM 
(n = 3 mice/group)  
 
Expression of GFP in the Kidney 
We then examined the expression of GFP protein in septic and non-septic kidney. As 
shown by the western blot (Figure 8), there was no statistically significant difference of GFP 
protein normalized data in kidneys of ChAT-eGFP septic kidneys as compared to kidneys from 
control mice. (Sham: 101 ± 10 and CLP: 99 ± 8 (arbitrary units); n=6 per group, P > 0.05). This 
reinforced the non-neuronal eGFP density evaluations that also showed no change in the cortical 
non-neuronal eGFP percentage. 
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Figure 8. GFP protein content in ChAT-eGFP septic kidneys. A: Representative Western blot of 
renal GFP protein; B: Densitometry of GFP bands normalized to β-actin, expressed as arbitrary 
units with no statistical difference between groups (p = 0.8733). Protein was extracted from the 
kidney and used for western blot analysis of GFP. β-actin was used as loading control. Data was 
expressed as the mean + SEM (n = 6 mice/group). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A. 
B. 
35 
 
CHAPTER 4 
DISCUSSION AND CONCLUSIONS 
 
A previous study has shown that sympathetic nerve fiber density in the spleen was 
elevated during acute sepsis due to a neuronal sprouting response triggered in the spleen (Hoover 
et al. 2014). The researchers used the same sepsis model as in our experiments, and there was an 
upregulation of nerve growth factor (NGF) in the spleen and consequent rapid growth of 
noradrenergic nerve fibers. The researchers proposed that the effects of NGF could be 
widespread in sepsis. Therefore, to test if the same effect is happening in the kidney we 
underwent this project. There is evidence that sepsis and rheumatoid arthritis (RA) can induce 
sprouting in sympathetic nerve fibers as studies have shown elevated TH expression in the gut of 
septic mice (Zhou et al. 2004), and sympathetic nerve fiber density is increased in the spleen in a 
RA rat model (Lorton et al. 2005). Our hypothesis was that during sepsis, which is a stressful 
situation, the renal sympathetic innervation will increase. The present work revealed the effects 
of acute sepsis on sympathetic innervation of the kidney as well as on renal structural changes 
and function.  
Our findings showed that there was no significant difference in renal sympathetic 
innervation between the groups during sepsis, after analyzing TH nerve density in the renal 
cortex (Figure 4). Furthermore, sepsis did not affect the renal TH protein content (Figure 5) as 
there was no statistically significant difference between the groups. For the TH protein analysis, 
we studied the whole kidney, while the TH nerve density measurement was focused more on the 
cortical region of the kidney where the vast majority of nerves are located.  
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Acute sepsis did not increase the renal sympathetic nerve density by inducing 
noradrenergic nerve sprouting, which contrasts with the elevated nerve level that occurred in the 
spleen, although the same septic model was used (Hoover et al. 2014). This difference suggests 
that sprouting of sympathetic nerves is not a general phenomenon in sepsis and may be limited to 
lymphoid tissue or related to immune cells solely. Moreover, a prominent difference between 
both organs is that the spleen is a primary organ for initial response to PAMPs and DAMPs. 
Furthermore, in the spleen, it was shown that NGF was increased during acute sepsis (Hoover et 
al. 2014). The mechanism of sympathetic nerve sprouting in the spleen during an inflammatory 
response is likely that splenocytes produce NGF that binds to neurotrophin receptors on 
sympathetic neurons, which causes outgrowth of TH-positive neurites into the spleen. In other 
words, increased NGF synthesis in the spleen during sepsis may have led to an increase in 
sprouting of sympathetic fibers.  In our study, there was no renal sprouting of noradrenergic 
nerves during sepsis and so this could indicate that increased NGF synthesis and release did not 
occur.  
Since TH is the rate limiting enzyme in the catecholamine synthetic pathway that includes 
DA, NE and EPI, any change in TH expression should correlate with catecholamine synthesis. 
After measuring renal catecholamines by HPLC at 16 h post-surgery, no differences between 
groups were detected for NE, EPI or DA (Figure 6). This goes hand in hand with our previous 
TH nerve density results as well as the TH protein expression data that had no change between 
the two groups.  
The mice that were used to examine the catecholamine levels were perfused in order for 
the circulating catecholamines to not affect the measurements. Surprisingly, the mouse 
kidneys had eight times more epinephrine than norepinephrine in both the sham and CLP 
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groups. This is most likely due to uptake of circulating epinephrine by renal sympathetic 
nerves and may have no correlation with the sepsis condition. NE is known to be the main 
neurotransmitter involved in sympathetic nerves. However, studies have shown that EPI acts 
on tubular adrenergic receptors and is regulated directly in the kidney by being incorporated 
into postganglionic sympathetic nerves. EPI is released with NE during renal sympathetic 
nerve firing for, up to 24 h after its uptake, (Majewski et al. 1981; Quinn et al. 1985; Desir and 
Peixoto 2013). EPI’s main site of action is on β2-receptors with a very high affinity compared 
to other endogenous compounds (Lands et al. 1967). Renal EPI synthesis may be of 
importance to renal function as tubular α receptors increase sodium reabsorption and renal β 
receptors stimulate renin release (Kennedy et al. 1995).  N-methylation of NE leads to EPI 
synthesis, and various N-methylating enzymes are found throughout animals and humans 
(Kennedy et al. 1995). Of the several enzymes, non-adrenal phenylethanolamine N-
methyltransferase (PNMT) is the only one that has been documented to synthesize EPI in vivo 
(Kennedy et al. 1995).  The location of PNMT in the renal glomeruli and tubules suggests that 
the kidney may synthesize EPI at sites predisposing it to urinary excretion (Kennedy et al. 
1995). The rat kidney synthesizes and excretes EPI even with their adrenal glands removed 
(Ziegler et al. 1989). Similarly, EPI was also found in the urine of humans that had their 
adrenal glands removed (Von Euler 1961).  
Our second part of the study was to examine the effects of acute sepsis on renal structural 
changes in the kidneys. H & E as well as PAS staining (Figure 1) were done on the kidney 
tissues. We found that 16 h post-surgery, there were bubble cells visible only in the renal tubules 
of CLP mice. The bubbles were defined as being clear, homogeneous and spherical in 
appearance possessing fluid-filled spaces under a light microscope (Racusen et al 1988). Graber 
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et al. suggested that these bubble cells represent viable renal tubular cells that have been injured 
sub-lethally (Graber et al 1991). This acute renal pathology is thought to be reversible. The 
bubble cells were found to be present the highest in patients with ATN and almost always 
accompanied by normal-appearing renal tubular cells (Graber et al 1991). Moreover, most of the 
bubble cells excluded trypan blue, indicating normal membrane integrity. Through an electron 
microscope, no mitochondrial changes were seen in bubble cells that may characterize dead 
cells. (Graber et al 1991). In addition, LeMasters et al. and Herman et al have defined three 
stages of cell injury in these models (LeMasters 1987; Herman et al. 1988). In the first and 
earliest stage of injury, the cells begin to develop clear vesicles while in the second stage the 
vesicles enlarge and coalesce. Despite the gross distortion of cellular morphology at this time, 
these stage 2 cells are viable since they exclude trypan blue. Moreover, the vesicles resorb once 
ischemia is relieved. An irreversible transition from stage 2 to stage 3 happens if there becomes 
sudden rupture of one of the surface vesicles, after which the cell freely admits trypan blue. A 
similar vacuolar change is also described in both human ATN and animal models (Taggert et al 
1968). 
Another important structural change was that Bowman’s space was significantly 
diminished in renal corpuscles of septic mice compared to the sham kidneys 16 h post surgery 
(Figure 2). This may indicate a disruption in the glomerular filtration capacity in the CLP 
kidneys. GFR may be determined from the equation of NFP where NFP = Pc – PB – πc. (Pc is the 
hydrostatic pressure in the glomerular capillaries, PB is the hydrostatic pressure in Bowman’s 
space and πc is the oncotic pressure in the glomerular capillaries; Kellum 2015). The hydrostatic 
pressure is the pressure exerted directly by fluid on the capillary walls of the glomerulus or 
Bowman's capsule (Deshmukh and Wong 2009). Since the Bowman’s space shrinked 
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significantly in CLP kidneys, this only indicates that there is an increase in hydrostatic pressure 
in Bowman’s space (PB) which, if the other factors stayed constant, consequently suggests that 
NFP is decreased and therefore the GFR should decrease as well. However, renal function was 
not impaired in CLP mice 16 h post-surgery, since there was no significant difference in serum 
CystC levels (Figure 3). CystC may be useful for determining GFR (Finney et al. 2000) since in 
several studies, an obvious relationship was linked between the CystC and GFR in adults 
(Simonsen et al. 1985; Bökenkamp et al. 1998). Moreover, CystC production is not influenced 
by sepsis and therefore is a potentially valuable specific and sensitive marker of kidney function 
in septic conditions (Gerbes et al 2002; Schuck et al. 2002; Mårtensson et al. 2012). These 
results imply that the kidney function is still working properly and that acute sepsis does not 
cause permanent kidney damage at 16 h in our CLP model although there was a decrease in 
Bowman’s space. Moreover, this may lead us to propose that there are compensatory factors 
such as the (Pc) and (πc) that may play a role in allowing normal renal filtration to proceed. 
However, these factors which are the hydrostatic pressure and oncotic pressure in the glomerular 
capillaries respectively were undetermined in our experiments. In conclusion, the glomerular 
filtration capacity or renal function did not seem to be distorted although early, reversible 
pathological changes were evident in the CLP renal tubules.  
The kidneys contain cholinergic tubular cells (GFP+) that are not affected by acute 
sepsis; however, they may have an important role in renal physiology and pathophysiology. 
Neither the density of GFP+ cells in confocal analysis nor the abundance of GFP in Western blot 
was different between the groups after 16hrs in our acute sepsis model (Figure 7 and 8). Several 
players of the cholinergic system have been found to be present in the renal tubular tissues. This 
includes acetylcholinesterase enzyme suggesting that acetylcholine (ACh) may be synthesized 
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from circulating choline in the kidney (Kopp; 2011). In addition, muscarinic ACh receptors 
(mAChRs) were found in glomeruli, proximal tubules and the collecting duct, so renal ACh may 
affect solute transport (McArdle et al. 1988; McArdle and Garg 1989; Nitschke et al. 2001; 
Robey et al. 2001; Johns and Kopp 2012). ChAT has been found in non-neuronal cells that 
regulates ion and fluid balance (Wessler et al. 2008; Jun et al. 2014). Tubular epithelial cells in 
the kidney play an important role in the inflammatory response by producing cytokines, growth 
factors and hormones that affect the function of the non-neuronal cholinergic system, including 
ACh, through a neural-immune interaction (Wessler and Kirkpatrick 2008). Non-neuronal ACh 
release is not completely understood; however, during acute inflammatory states, ACh released 
by the vagal nerve through α7-nAChRs, may have anti-inflammatory effects (Pavlov and Tracey 
2005; De Jonge and Ulloa 2007). Moreover, inhibition of the release of proinflammatory 
mediators such as TNF and IL1-β from immune cells occurs (Pavlov and Tracey 2005; De Jonge 
and Ulloa 2007).   
In conclusion, our hypothesis that there will be an upregulation in sympathetic 
innervation to the kidney during sepsis was not proven to be true. Neither the TH protein content 
nor the TH nerve density in the mice kidneys was altered. This differs with the previous spleen 
model where the noradrenergic nerve sprouting was seen and therefore we may conclude that the 
sprouting of sympathetic nerves is not a general phenomenon in sepsis and may be limited to 
lymphoid tissue or related to immune cells solely. Moreover, this may indicate that increased 
NGF synthesis has not happened. The kidney may not have a bulk of immune cells infiltrating it 
yet or the kidney may not be in close proximity to the spleen in order for neuro-immune reaction 
to occur. In addition, acute sepsis did not affect the static measures of the non-neuronal 
cholinergic system. Bowman’s space was diminished with cortical bubble cells present 
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suggestive of acute renal pathology, however, renal function was unchanged. Furthermore EPI 
was found to be tremendously higher than NE in our mice kidneys although they were perfused. 
This may lead us to propose that PNMT found in the kidney may have an important role in 
regulating EPI synthesis; however, the mechanism and consequences of elevated EPI in mouse 
kidney are still yet to be determined. Some future aims in working on this project include 
measuring the NGF in the kidneys during sepsis to see if it is elevated or not. Moreover, using a 
prolonged septic model (e.g. 24h) may give time for severe renal damage to happen and allow us 
to investigate if there is a change in sympathetic innervation as well as non-neuronal cholinergic 
cells expression under these conditions.  
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APPENDIX 
Abbreviations 
 
ATN                         Acute tubular necrosis 
Ach                          Acetylcholine 
ChAT                       Choline acetyltransferase           
CLP                          Cecal ligation and puncture 
CystC                       Cystatin C 
DA                           Dopamine 
DAMPs                    Damage-associated molecular patterns 
DHBA                      Dihydroxybenzoic acid 
EPI                           Epinephrine 
GFP                          Green fluorescent protein 
GFR                         Glomerular filtration rate 
H                              Hours 
H and E                    Hematoxylin and eosin 
HMGB1                   High mobility group box 1 
HSP                          Heat shock protein 
IL                             Interleukin 
LPS                          Lipoplysaccharide 
M/S                          Meters/second 
MIN                         Minutes 
NE                            Norepinephrine 
NFP                          Net filtration pressure 
NO                           Nitric oxide 
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OSA                         1-octanesulfonic acid sodium 
PAMP                      Pathogen associated molecular pattern 
PAS                          Periodic acid schiff 
PBS                          Phosphate buffer saline 
PRR                         Pattern recognition receptor 
ROS                         Reactive oxygen species 
S                               Seconds 
SIRS                         Systemic inflammatory response syndrome       
SNA                         Sympathetic nerve activity 
TH                            Tyrosine hydroxylase 
TLR                          Toll like receptor 
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